BackApimeds Pharmaceuticals US Overview

Apimeds Pharmaceuticals US Goodwill

Track Apimeds Pharmaceuticals US's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average / median

Loading

Apimeds Pharmaceuticals US Goodwill History

Loading

Apimeds Pharmaceuticals US vs. peers: Goodwill Comparison

Loading

Apimeds Pharmaceuticals US Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apimeds Pharmaceuticals US (APUS) FAQ

The latest goodwill for APUS is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Apimeds Pharmaceuticals US's historical trend and sector peers before judging valuation or financial health.

Over the past year, APUS's goodwill moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apimeds Pharmaceuticals US's operating scale or balance-sheet position.

A goodwill figure of $0 for APUS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting APUS's goodwill ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.